Since the early 1980s, the emergence of fluorescence in situ hybridization (FISH) technology has opened a new chapter in biomedical research. This technology uses specific fluorescent probes to efficiently and accurately detect and locate specific DNA sequences on chromosomes. With the advancement of science and technology, the application scope of FISH continues to expand, from genetic diagnosis to cell biology, and even cancer research, all showing its significant influence.
FISH is widely used to explore specific characteristics of DNA and RNA, allowing scientists to conduct in-depth analysis of different biological samples.
The basic principle of fluorescence in situ hybridization technology is to use a single-stranded DNA or RNA probe that is complementary to the target sequence. This probe can be bound to specific locations within cells and its specific location can be observed through fluorescence microscopy, thereby revealing the spatiotemporal pattern of gene expression. In the diagnosis of cancer, FISH can provide valuable information for clinical medicine, such as helping to determine whether there are chromosomal abnormalities, which is crucial for the early diagnosis of many diseases.
Over time, FISH technology has evolved into various variants, such as single-molecule RNA FISH (smFISH) and microfluidic FISH (MA-FISH). These technologies continue to improve in detection accuracy and sensitivity, allowing researchers to observe gene expression with higher resolution. Especially in single-molecule RNA FISH, researchers can observe a large number of mRNA molecules simultaneously, providing important insights into gene regulatory networks.
These technologies not only facilitate the exploration of gene functions in basic research, but are also gradually being used in clinical diagnosis, laying the foundation for personalized medicine.
FISH technology has a wide range of medical applications, including the diagnosis of rare genetic diseases and the prognosis assessment of cancer. For example, FISH can provide in-depth analysis of the DNA of children whose parents have developmental disabilities to provide more detailed family planning recommendations. In addition, the application of FISH in pathology allows scientists to more clearly identify chromosomal abnormalities in various cancers such as chronic myelogenous leukemia and acute lymphoblastic leukemia.
In addition to disease diagnosis, FISH also plays an important role in the field of microbiology, for example in the identification of pathogens. In the face of the rapid evolution of antibiotics, being able to quickly and accurately identify pathogens is of great significance for timely treatment. For evolutionary studies between species, FISH technology allows researchers to intuitively reveal the similarities and differences in genomes between different species, increasing our understanding of the evolution of life.
Looking to the future, FISH technology will continue to develop toward high-throughput and diversification. Many new technologies, such as MERFISH and Q-FISH, will further improve the resolution of genomic research and play a key role in precision medicine, cancer research and gene editing. With further exploration and improvement of FISH technology, it will have a more profound impact in medical and basic biological research.
The successful application of FISH technology not only changes the way medicine is practiced, but also promotes the pace of scientific progress. We can’t help but ask, with the deepening of genetic research, what new breakthroughs will FISH technology bring?